ArticleJournal of cancer research and clinical oncology2022

Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study.

Ziyi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.